Acute Toxicity Profile and Early Efficacy Results of De-Escalated, Risk-Directed Post-Operative Adjuvant Therapy for Human Papillomavirus-Positive Oropharynx Squamous-Cell Carcinoma: A Phase 2 TrialZ. Jose, Douglas R. Adkins, Ryan S. Jackson et al.|International Journal of Radiation Oncology*Biology*Physics|2022Cited by 1